Medicare and Medicaid cover only those CGM devices approved by the U.S. Food and Drug Administration as a replacement for fingerstick blood glucose testing for diabetes treatment decisions (i.e., "therapeutic" use), and only if patients are receiving intensive insulin therapy and require frequent...